Lindsay Rein, MD
Hematology · Durham, NCNPI 1457526659
Payments from drug & device makers
Across 1,094 payments — averaging $3402.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$1.5M
- Novartis$808K
- Pharmaessentia USA Corporation$438K
- Sumitomo Pharma America, Inc.$415K
- Blueprint Medicines Corporation$295K
- Bristol Myers Squibb$82K
- plus $160K from 9 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 123 | $1,523,704 |
| Novartis | 15 | $808,016 |
| Pharmaessentia USA Corporation | 48 | $437,837 |
| Sumitomo Pharma America, Inc. | 721 | $415,249 |
| Blueprint Medicines Corporation | 42 | $295,242 |
| Bristol Myers Squibb | 5 | $81,992 |
| Karyopharm Therapeutics Inc. | 22 | $66,614 |
| Geron Corporation | 79 | $40,522 |
| Sobi, Inc | 9 | $20,056 |
| Merck | 9 | $9,185 |
| Sanofi US Services Inc. | 4 | $7,612 |
| AbbVie | 9 | $7,586 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $4,052 |
| CTI Biopharma Corp. | 3 | $2,985 |
| Morphosys, US Inc. | 2 | $1,798 |
How this compares
$3,722,450 in reported general payments places this provider in the 90th percentile of 65 hematology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Durham
- Sascha TuchmanDurham$6.8M
- Thomas OrtelDurham$3.2M
- Gowthami ArepallyDurham$735K
- Alan CarlsonDurham$143K
- Jadee NeffDurham$71K
- Oluwatoyosi OnwuemeneDurham$19K
- Edward BuckleyDurham$6K
- Andrew PeseskiDurham$371
- Charity OyedejiDurham$125
- Alan Zausner SkarbnikCharlotte$9.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.